Medications and Drugs
Brand Names: Ventavis
Generic Name: iloprost inhalation (Pronunciation: ill O prost)
What is iloprost inhalation (Ventavis)?
Iloprost inhalation is an synthetic prostacyclin. It works by opening blood vessels in the lungs.
Iloprost inhalation is used to treat pulmonary arterial hypertension (PAH). It decreases symptoms of this condition and improves your ability to exercise.
Iloprost inhalation may also be used for purposes not listed in this medication guide.
What are the possible side effects of iloprost inhalation (Ventavis)?
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:
Less serious side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is the most important information I should know about iloprost inhalation (Ventavis)?
Iloprost inhalation is usually given 6 to 9 times per day. Your doses should not be spaced less than 2 hours apart, even if you feel like the effects of the medicine have worn off in less than 2 hours.
Iloprost should be used only with the I-neb ADD System, or the Prodose AAD System. Do not use iloprost inhalation with any other type of nebulizers. You will be shown how to use your nebulizer at home.
This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Avoid getting up too fast from a sitting or lying position, or you may feel dizzy. Get up slowly and steady yourself to prevent a fall.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Lung Disease/COPD Resources
- 10 Symptoms of a COPD Flare-Up
- Are You At Risk for COPD?
- 6 Health Tips During Lung Cancer Immunotherapy